Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


NZ bioscience looks to Asia for bright future

Media release February 26 2013

NZ bioscience looks to Asia for bright future

New Zealand bioscience is focusing on Asia, with a firm eye on opportunities in China.

Professor Zhong Yang, Dean of the Graduate School of Fudan University in Shanghai, is to be one of the key note speakers at the sector’s annual conference being held in Auckland March 18 - 20. He will speak on bioscience trends in China and the opportunities for collaborative work.

Professor Zhong studied in the fields of molecular evolution of plants, bioinformatics and analysis and computer simulation of systems biology. More recently he has focused on China’s medium and long-term technology development plans as well as contemporary issues on energy saving and emission reduction, development of renewable energy and its energy economy strategy.

Professor Zhong will be immediately followed by Dr Janette Dixon, who will share her views on how New Zealand’s bioscience companies can leverage Asia. Dr Dixon is senior vice president of QRxPharma, which is focused on the development and commercialisation in 2013 of new treatments for pain management and central nervous system disorders.

The “Go Asia” theme is continued throughout the three day conference. Dr Paul Tan, chair of NZBIO, says the theme complements New Zealand’s trade focus and agreements, as well as the rapid development of the bioscience sector throughout Asia.

“Whereas the New Zealand bioscience sector once looked mostly to the United States and Europe, and to some extent Singapore, for funding and commercialisation opportunities, both the global financial crisis and the rapid growth of markets throughout Asia has meant it has become prudent to look more broadly throughout Asia,” Dr Tan says.

NZBIO is celebrating its 10th anniversary this year and chief executive Dr George Slim says while the successes will be celebrated and the difficult moments and failures will be remembered, the sector is optimistic about its future.

“From agbiotech to pharma, from biologics to therapeutics and from biofuel to diagnostics, more than 300 delegates from around the world will get a chance to consider how to drive the success of bioenterprise in New Zealand,” Dr Slim says.

The conference will conclude with a forum that considers that challenge for the future.

Ends


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Royal Society: Review Finds Community Water Fluoridation Safe And Effective

A review of the scientific evidence for and against the efficacy and safety of fluoridation of public water supplies has found that the levels of fluoridation used in New Zealand create no health risks and provide protection against tooth decay. More>>

ALSO:

Scoop Business: Croxley Calls Time On NZ Production In Face Of Cheap Imports

Croxley Stationery, whose stationery brands include Olympic, Warwick and Collins, plans to cease manufacturing in New Zealand because it has struggled to compete with lower-cost imports in a market where the printed word is giving way to electronic communications. More>>

ALSO:

Prefu Roundup: Forecasts Revised, Surplus Intact

The National government heads into the election with its Budget surplus target broadly intact, delivering a set of economic and fiscal forecasts marginally revised from May to reflect weaker commodity prices and a lower tax take. More>>

ALSO:

Convention Centre: Major New SkyCity Hotel And Laneway For Auckland

Today SKYCITY Entertainment Group Limited revealed plans to build a new hotel and pedestrian laneway of bars, restaurants and boutique shopping on land it owns in the Nelson and Hobson Streets block, expanding the SKYCITY Entertainment Precinct. More>>

ALSO:

Igniting The Spark: Bringing The Digital Enabler To Life

Changing a name is, relatively speaking, the easy part of a re-invention. Changing a culture, getting all the ducks in a row, turning yourself inside-out to become customer-inspired is a much bigger challenge. More>>

ALSO:

Ebola And NZ: Targeted Screening At Airport But Risk Low

The risk of any cases of Ebola in New Zealand remains very low, but health and border authorities are well prepared... anyone arriving in New Zealand who in the last three weeks has visited countries affected will be screened for symptoms of the disease. More>>

ALSO:

Scoop Business: Brewer Seeking Crowd-Funding Cancels Shareholders’ Dividends

Shareholders in Renaissance Brewing company, the first business to seek equity through crowd-funding in New Zealand, have cancelled their claim on $147,000 of accumulated earnings “to make Renaissance a more attractive investment opportunity.” More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news